DarioHealth Corp (NAS:DRIO)
$ 7.74 -0.45 (-5.78%) Market Cap: 75.41 Mil Enterprise Value: 87.22 Mil PE Ratio: 0 PB Ratio: 0.91 GF Score: 48/100

Q1 2025 DarioHealth Corp Earnings Call Transcript

May 14, 2025 / 12:30PM GMT
Release Date Price: $13.2 (-8.50%)

Key Points

Positve
  • DarioHealth Corp (DRIO) signed 14 new clients in Q1 2025, including a national health plan, a regional plan, and 12 employer partners, with over 80% of contracts being multi-condition.
  • The company achieved a 17% year-over-year revenue increase, driven by recurring revenue growth from B2B2C channels.
  • Non-GAAP gross margins expanded to 70.5%, with core business sustaining above 81% gross margins for four consecutive quarters.
  • Operating expenses declined by 35% year-over-year, demonstrating progress towards a more scalable model.
  • Strategic partnerships with virtual providers like Rula and Mediobis enhance DarioHealth's ability to deliver personalized care and scalability.
Negative
  • Sequential revenue was lower compared to Q4 due to a shift in scope with a large national health client and timeline extensions in other projects.
  • Tariff-related pressures impacted both outsourcing and partner-side execution, causing unexpected changes in revenue.
  • The pharma channel, contributing only 5% to 10% of revenues, faces potential slowdowns due to external factors like tariffs and drug price controls.
  • A large client transition from a mental health offering to a broader suite caused a decline in revenue for the quarter.
  • The path to achieving cash flow break-even by year-end relies heavily on successful launches and revenue growth from new and existing accounts.
Operator

Good morning, ladies and gentlemen, and welcome to the DarioHealth first quarter 2025 results conference call. (Operator Instructions) I would not like to turn the conference over to Kat Parrella, Investor Relations Manager at Dario. Kat, please go ahead.

Kat Parrella DarioHealth Corp;Investor Relations Manager

Thank you, operator, and good morning everyone. Thank you for joining us today for a discussion of Dario Health's first quarter 2025 financial results.

Leading the call today will be Eres Rafael, Chief Executive Officer of Dario Health. He'll be joined by Lara Dodo, our acting Chief Operating Officer. Lara's remarks have been prepared by our Chief Commercial Officer, Stephen Nelson, who is unable to attend today due to an injury requiring medical attention. Fortunately, he's expected to recover quickly, and we're grateful to Lara for joining us today on his behalf.

An audio recording and webcast replay for today's call will also be available online as detailed in the press release invite for this call.

For the benefit

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot